Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 425 of 2228 entries
View as:

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BI 10773 in Type II Diabetes Patients With Different Degrees of Renal Impairment

Phase: N/A Priority: Normal
NCT ID: NCT01907113 Org: User:
Start: 07/31/09 End: 12/31/09 Due: 12/31/10

Relative Bioavailability and Tolerability of Two New Different Extended Release Capsules of BIBV 308 SE, Versus a Solution of BIBV 308 SE in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02223013 Org: User:
Start: 04/30/99 End: - Due: -

Safety, Pharmacokinetics, and Pharmacodynamics of BIRT 2584 XX Administered as Multiple Doses and Safety and Pharmacokinetics of BIRT 2584 XX Administered With and Without Food as Single Dose to Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02256761 Org: User:
Start: 01/31/05 End: - Due: -

Safety, Tolerability and Pharmacokinetics of Multiple Rising Doses of BI 201335 NA in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02182362 Org: User:
Start: 05/31/07 End: - Due: -

Regulatory Request NIS in Korea

Phase: N/A Priority: Normal
NCT ID: NCT03642717 Org: User:
Start: 08/21/18 End: 04/30/20 Due: 04/30/21

Effects of Steady State Tipranavir/Ritonavir or Darunavir/Ritonavir or Ritonavir on Platelet Function, Coagulation and Fibrinolysis Biomarkers in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02251795 Org: User:
Start: 08/31/07 End: - Due: -

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Single and Multiple Doses of Linagliptin Tablets in Patients With Different Degrees of Renal Impairment in Comparison to Subjects With Normal Renal Function

Phase: N/A Priority: Normal
NCT ID: NCT02191228 Org: User:
Start: 04/30/08 End: - Due: -

Relative Bioavailability of a Linagliptin+Metformin Fixed Dose Combination Tablet Administered With and Without Food to Healthy Male and Female Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02223026 Org: User:
Start: 01/31/10 End: - Due: -

Safety and Efficacy of BIBF 1120 at High Dose in Idiopathic Pulmonary Fibrosis Patients

Phase: N/A Priority: Normal
NCT ID: NCT01335464 Org: User:
Start: 04/30/11 End: 10/31/13 Due: 10/31/14

Influence of Food on the Bioavailability of Telmisartan / Ramipril Fixed Dose Combination in Healthy Male and Female Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02214966 Org: User:
Start: 10/31/07 End: - Due: -

Afatinib (BIBW 2992) in Advanced Non-Small Cell Lung Cancer Patients With EGFR Mutation

Phase: N/A Priority: Normal
NCT ID: NCT01953913 Org: User:
Start: 09/30/13 End: 07/06/18 Due: 07/06/19

A Study of BI 765128 in Patients With an Eye Condition Called Diabetic Macular Ischemia Who Have Received Laser Treatment

Phase: N/A Priority: Normal
NCT ID: NCT04919499 Org: User:
Start: 07/30/21 End: 08/07/23 Due: 08/07/24

Safety and Effectiveness of Spiriva in COPD (Chronic Obstructive Pulmonary Disease) Patients Under the Real Condition of Usual Practice

Phase: N/A Priority: Normal
NCT ID: NCT00624377 Org: User:
Start: 12/31/07 End: - Due: -

Volasertib in Japanese Patients With Acute Myeloid Leukemia (AML)

Phase: N/A Priority: Normal
NCT ID: NCT01662505 Org: User:
Start: 08/31/12 End: 05/31/15 Due: 05/31/16

Changes in Physical Functioning in Patients With COPD During Therapy With a Combination Inhalation Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02173769 Org: User:
Start: 06/30/14 End: 03/31/15 Due: 03/31/16

Study of New Tablet Formulations and Suspension Formulation Compared to Current (1B) Formulation of BILR 355 BS in Healthy Male Volunteer Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02259868 Org: User:
Start: 06/30/05 End: - Due: -

Bioavailability of Ibuprofen Enantiomers Compared With Standard Brufen Sirup in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02182960 Org: User:
Start: 09/30/98 End: - Due: -

Bioavailability of Tiotropium + Olodaterol Fixed-dose Combination (5 μg/ 5 μg) in Chinese COPD Patients

Phase: N/A Priority: Normal
NCT ID: NCT02969317 Org: User:
Start: 02/24/17 End: 06/15/17 Due: 06/15/18

Dose Extension Study of BIIX 1 XX in Healthy Young Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02198287 Org: User:
Start: 01/31/99 End: - Due: -

Trial to Compare the Efficacy and Safety of a Single Bolus of TNK-tPA (Tenecteplase, Metalyse®) With Accelerated Infusion of Rt-PA (Alteplase, Actilyse®) in Asian Patients With Acute Myocardial Infarction

Phase: N/A Priority: Normal
NCT ID: NCT00148460 Org: User:
Start: 03/31/01 End: 02/28/06 Due: 02/28/07

This Study Combines Data From 3 Other Studies Testing Empagliflozin in Patients With Diabetes or With Chronic Heart Failure. The Study Looks at the Numbers of Patients Who Had Lower Limb Amputations

Phase: N/A Priority: Normal
NCT ID: NCT04937816 Org: User:
Start: 06/01/21 End: 07/13/21 Due: 07/13/22

Efficacy and Tolerability of Bisacodyl Sugar Coated Tablets, Simeticone Chewing Tablets and Their Combination in Constipation and Bloatedness

Phase: N/A Priority: Normal
NCT ID: NCT02211976 Org: User:
Start: 10/31/03 End: - Due: -

A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 1291583 in the Blood

Phase: N/A Priority: Normal
NCT ID: NCT03890887 Org: User:
Start: 04/12/19 End: 07/29/19 Due: 07/29/20

a PMS on Safety Profile of Pramipexole in Chinese Parkinson Disease Patients

Phase: N/A Priority: Normal
NCT ID: NCT01361009 Org: User:
Start: 05/31/11 End: 02/29/12 Due: 02/28/13

Relative Bioavailability of 1 mg and 10 mg BI 1356 BS as Powder in the Bottle (PIB) to 1 mg and 10 mg BI 1356 BS as Tablets as Single Oral Administration in Healthy Male Volunteers Including the Influence of Food on the Bioavailability of 10 mg BI 1356 BS

Phase: N/A Priority: Normal
NCT ID: NCT02180503 Org: User:
Start: 08/31/05 End: - Due: -